is retatrutide fda approved yet Will the approve retatrutide? Odds & Predictions Trial of next-gen weight-loss drug

Regular meal times help keep the GLP-1 "clock" synchronized

In NFP's recent annual employer survey, 51% of employers cited GLP-1s as the top driver of rising prescription drug costs

Our team strongly advises against it

Most Americans do not use GLP-1s long enough to see meaningful weight-loss owenhaskins Jul 9, 2024 2 min read The largest study to date has reported that despite the explosion in demand for GLP-1s, 58% of patients discontinue use before reaching a clinically meaningful health benefit, according to research by the Blue Cross Blue Shield Association (BCBSA) and conducted by Blue Health Intelligence (BHI)

Energy Expenditure: Pre-clinical studies have highlighted Retatrutides GCGR-driven energy expenditure component as a particularly significant differentiator, with research documenting thermogenic and hepatic fat oxidation effects that add a distinct metabolic dimension beyond the appetite suppression and insulin secretion pathways shared with Tirzepatide and Semaglutide

Song, Y